Glaukos Corp. has reported it will initiate an IDE pivotal trial for its Istent SA trabecular micro-bypass system among pseudophakic glaucoma patients. Research will evaluate the device against selective laser trabeculoplasty (SLT) as well as safety and efficacy in reducing intraocular pressure (IOP) at one year. Read More
